Anastrozole and estrogen in men: why the goal is balance, not elimination

Anastrozol y estrógeno en hombres: por qué la meta es el equilibrio, no eliminarlo

A man's estrogen is not an accident

If you've read about testosterone online, you probably met estrogen cast as the villain. Something that "leaks" out and has to be cut. That is not how your body works.

Your testosterone doesn't travel alone. Part of it is converted into estradiol — the main form of estrogen — by an enzyme called aromatase. That conversion isn't a leak: it's a step in the plan. The estradiol circulating in your blood was made by your own body, out of your own testosterone, because it needs it for specific jobs.

And we know it needs it because some men are born unable to make it. Congenital aromatase deficiency, and cases of a defective estrogen receptor, are the living proof: in those men bone doesn't consolidate well and bone turnover accelerates. They aren't short on testosterone. They're short on what testosterone was supposed to become.

So the right question was never "how do I lower my estrogen." It was always: how do I get both hormones where they belong.

What estradiol actually does in your body

In 2013 the trial that is still the reference for this question was published, and it's built very elegantly.

400 healthy men aged 20 to 50 took part. In all of them, their own hormone production was shut down first, to start from zero. Then half received testosterone gel at five different doses, from none to a lot; the other half received the same thing plus anastrozole, to block the conversion to estradiol. That design made it possible to separate what each hormone does, instead of measuring them together:

• Testosterone deficiency accounted for the loss of lean mass, the loss of thigh-muscle size, and the loss of strength.
• Estrogen deficiency primarily accounted for the increase in body fat.
• Both together accounted for the decline in sexual desire.

Read that second line again, because it's the one that changes the conversation. If you push your estradiol too low, the measured effect was not "more definition." It was more fat.

There's a second effect that almost never gets mentioned: hot flashes. In that same group of men, vasomotor symptoms were reported at 26% of visits in the group without anastrozole and at 35% of visits in the group with anastrozole. The difference came from estradiol, not testosterone, and the sharpest change was between men with estradiol of 5 to 9.9 pg/mL and those at 10 to 14.9 pg/mL: 38% versus 16%.

In other words: low estradiol in a man looks more like what's described in menopause than you'd expect. That isn't a curiosity — it's the sign that you've overshot the brake.

Aromatase: the enzyme that lives in your fat

Here's the part that matters most if your reason for reading this is weight.

Aromatase isn't spread around at random: a substantial amount of it lives in fat tissue. The more body fat you carry, the more aromatase you have working, and the more of your testosterone gets converted into estradiol before it can do its job.

That has a well-described consequence: in men with obesity, that increased conversion contributes to low testosterone of central origin — hypogonadotropic hypogonadism. The excess estradiol tells the brain there's already enough hormone, the brain turns the order down, and the testis makes less.

It's a loop that closes on itself: more fat, more aromatase, less available testosterone, less muscle, less expenditure, more fat.

Seen that way, you can understand why blocking the enzyme sounds so logical. And in part it is. But when it was tested against the other option, the other option won.

What anastrozole is and what it does

Anastrozole is a non-steroidal aromatase inhibitor, taken by mouth. Its only job is to block that enzyme, so less estradiol is produced and testosterone stays in circulation without being converted.

It helps to know where it comes from. Anastrozole was approved for hormone-receptor-positive breast cancer in postmenopausal women, and that is still its approved use. The FDA-approved label contains no indication in men, and none for low testosterone. Its use in men is what's called off-label: legal, done by physicians every day, but without an approval behind it for that purpose.

We don't say that to scare you. We say it because it changes who makes the decision. An off-label medication is not a supplement: it's a conversation with a physician who knows your case and who is going to watch what happens.

What anastrozole does achieve

Let's be fair to the medication, because it does something real.

In a one-year randomized, placebo-controlled trial, 69 men aged 60 or older with low or borderline testosterone received anastrozole 1 mg daily or placebo. Mean testosterone rose from 319 ng/dL to 524 ng/dL at month 3, and was still 474 ng/dL at one year. Estradiol fell from 15 to 12 pg/mL and stayed there.

In a parallel trial of 88 men aged 60 or older, the pattern was the same: total and bioavailable testosterone rose markedly. The authors summed it up by saying anastrozole normalized androgen production.

If what you want is for the lab number to go up, it goes up. The question is: and then what?

Bone: the bill that doesn't show up in the lab

In those same trials, what happened to the body was measured too, not just the blood.

In the 88-man trial, with testosterone normalized for a full year, body composition did not change and strength did not change. Neither did PSA, prostate symptoms, hematocrit, or lipids.

In the 69-man trial, bone was measured. Spine bone mineral density decreased in the anastrozole group compared with placebo, with a statistically clear difference: while the placebo group rose slightly, the anastrozole group fell. The authors closed by saying aromatase inhibition does not improve skeletal health in aging men with low or low-normal testosterone.

That fits everything above: estradiol is the hormone that restrains bone resorption. Lower it, and bone is recycled faster than it's replaced. On the medication's own label, in the women it is approved for, bone loss and fractures appear among the common adverse reactions, along with a mean decrease in lumbar spine and total hip density, and elevated cholesterol in 9% versus 3.5% with tamoxifen.

This doesn't make it a bad medication. It makes it a medication that needs someone watching estradiol, not just testosterone.

The big lever: losing fat

Now the best part, and the reason this guide exists.

A randomized, double-blind, placebo-controlled trial asked exactly the question that matters. It took 23 men with severe obesity — body mass index of 35 or higher — aged 35 to 65, all with total testosterone under 300 ng/dL and the hormonal pattern of central hypogonadism. All of them were put on a weight-loss program of diet and exercise. On top of that, at random, half got anastrozole 1 mg daily and half got placebo. Six months.

At the end, the anastrozole group had higher testosterone and lower estradiol, as expected, and lost somewhat more fat mass.

But in what the person actually feels: changes in symptoms and in muscle strength did not differ between the two groups. And on two counts the group without anastrozole came out ahead: total and LDL cholesterol dropped more, and tibial trabecular bone was better preserved.

Put the most useful way: the weight was the lever; the medication was the garnish. Losing fat turns down the aromatase that was working overtime, and the hormonal balance moves in the right direction on its own — without the bill in bone or cholesterol.

And that's genuinely good news: what moves your hormonal profile most isn't locked inside a hard-to-get prescription. It's in visceral fat, muscle, sleep, and glucose — and all of that can be worked on.

Fertility: why anastrozole enters this conversation

There's one area where anastrozole is used with a different logic, and it's the reason many men hear about it at all.

Unlike testosterone gel or injections, an aromatase inhibitor doesn't shut off the brain's signal to the testis. The opposite: by lowering estradiol, it releases the brake and the brain sends more signal. That's why testosterone and FSH both rise. For a man who wants to improve his testosterone without compromising fertility that matters — external testosterone does the reverse, which is why the Endocrine Society guideline recommends against starting it in men planning fertility in the near term.

How well it works for fertility is another matter. A double-blind trial compared clomiphene 25 mg with anastrozole 1 mg over 12 weeks in 26 men with low testosterone and infertility. Both raised testosterone — clomiphene more; anastrozole improved the testosterone-to-estradiol ratio more. But neither significantly changed semen parameters or the patient-reported questionnaires.

A systematic review with network meta-analysis across 14 trials and 1,342 men was broader and reached the same place: there is insufficient evidence to support the routine use of clomiphene, tamoxifen, or aromatase inhibitors to optimize semen parameters. On sperm concentration, clomiphene came out ahead of the aromatase inhibitor.

If this is your situation, the conversation is with a urologist or fertility specialist. We have a separate guide on enclomiphene versus testosterone.

The number worth watching, and the one that isn't

The temptation is to look only at total testosterone and celebrate when it rises. But given all of the above, estradiol deserves to be on the same page. A man with testosterone of 600 and estradiol of 8 pg/mL isn't necessarily better off than before: he may be losing bone, gaining fat, and having hot flashes, while the number he's watching looks excellent.

On diagnosis, the Endocrine Society guideline is specific and worth knowing: the diagnosis is made only in men with consistent symptoms and signs and consistently low testosterone; total testosterone is measured fasting in the morning with a reliable assay; and it's confirmed by repeating the measurement on another fasting morning. A single lab, drawn in the afternoon after a bad night, is not a diagnosis.

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. What's usually looked at, and why, is covered in men's hormonal health.

So your expectations are the right ones

Here's what this evidence lets you expect, and what it doesn't:

• Yes: anastrozole raises testosterone in men measurably, and does it without shutting off the brain's signal to the testis.
• Not yet: in the one-year trials, that rise did not translate into more muscle, more strength, or better body composition. The authors themselves called for larger trials before it could be considered a treatment option for low testosterone in older men.
• With monitoring: lowering estradiol has a cost in bone. The spine lost density in the trial that measured it, and bone loss and fractures are on the medication's label.
• What does move the needle: losing fat. In the head-to-head comparison, doing it without the medication gave the same symptoms and the same strength, with better cholesterol and better bone.
• What nobody can promise you: a number, a timeline, or a result. Individual results vary and are not guaranteed. If someone guarantees you a figure, that only tells you something about the person guaranteeing it.

And one more honest thing: polymorphisms of the aromatase gene, CYP19A1, have been described that influence hormone profile and treatment response. Two men with the same lab may not respond the same way. That's why this is decided case by case and not by protocol.

Who is this NOT for?

This section does not get shortened. If you're in any of these groups, tell your physician before starting, even if it seems minor:

• If you have osteoporosis, osteopenia, or have had a fragility fracture. Lowering estradiol runs directly against your bone.
• If you have a strong family history of osteoporosis, or other factors already thinning your bone.
• If your estradiol is already low. Not every man with low testosterone has high estradiol, and blocking an enzyme that isn't working overtime leaves only the harm.
• If your cholesterol is high or poorly controlled. Elevated cholesterol is among the described effects.
• If you have prostate or breast cancer, a prostate nodule or induration, or an elevated PSA without urological evaluation. This applies to anything that raises your testosterone.
• If you have elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure, or a heart attack or stroke in the last six months.
• If you have symptoms but only one low lab, or none. Diagnosis requires symptoms plus repeated fasting morning measurements.
• If you have no symptoms and just want the higher number. There's no evidence that gives you anything, and there is evidence of what it costs.
• If what you're looking for is a shortcut around working on weight, sleep and strength. In the head-to-head comparison, those are what won.
• If you won't be able to follow up. A medication that moves two hormones in opposite directions needs someone watching both.

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. If your case points to this not being for you, we'll tell you. Your trust is worth more than a sale.

GLP-1 programs with FDA-approved medications (Wegovy®, Foundayo™, Ozempic®) from $149/month, by telemedicine, in Spanish and English

If what you read above sounded familiar — the weight that won't move, the energy that won't come back, the lab saying one thing and the body another — the best-evidenced lever is body fat, and there we can help. Real clinical supervision, in English and Spanish, with continuous follow-up. Cancel whenever you want, one click.

Eligibility is determined by medical evaluation. Individual results vary and are not guaranteed.

Frequently asked questions

Is estrogen bad for men?

No. Your body makes it out of your own testosterone because it needs it: it restrains bone resorption, helps keep body fat in check, and takes part in desire. Men born unable to make it have bone problems, not advantages.

Does anastrozole raise testosterone?

Yes, measurably. In a one-year trial in men aged 60 or older, mean testosterone rose from 319 to 524 ng/dL by month 3 and was still 474 ng/dL at one year.

Then why doesn't everyone take it?

Because in those same trials the rise did not translate into more muscle, more strength, or better body composition, and spine bone density fell compared with placebo. The number improves; what the person feels, in those studies, did not.

Is it better than losing weight?

In the only trial that compared them head to head, no. In men with severe obesity, losing weight with and without anastrozole gave the same change in symptoms and strength — and the group without the medication did better on cholesterol and bone.

Is it FDA-approved for men?

No. The approved label covers hormone-receptor-positive breast cancer in postmenopausal women. There is no indication in men and none for low testosterone. Use in men is off-label and is an individual medical decision.

Does it affect fertility the way testosterone does?

It works the other way: it doesn't shut off the brain's signal to the testis, it releases it, which is why testosterone and FSH rise. But in trials it did not significantly improve semen parameters, and a review of 14 trials and 1,342 men found insufficient evidence for routine use with that goal.

What estradiol should a man have?

There's no number we can give you over the internet, and the range depends on the assay. What was seen is that below 10 pg/mL hot flashes were considerably more frequent. It's a value your physician should read alongside testosterone, not instead of it.

Can I take it together with testosterone?

That's strictly a medical decision, with estradiol monitored. What has no support is adding it on your own "just in case": if your estradiol isn't high, lowering it leaves only the cost in bone.

Do I need labs before starting?

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. It isn't automatic or required for everyone.

Do you serve Spanish speakers?

Yes. All of our content and care are available in Spanish.

Sources

• Finkelstein JS, Lee H, Burnett-Bowie SM, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011-1022. — DOI · via PubMed
• Burnett-Bowie SM, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. 2009;94(12):4785-4792. — DOI · via PubMed
• Burnett-Bowie SM, Roupenian KC, Dere ME, Lee H, Leder BZ. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2009;70(1):116-123. — DOI · via PubMed
• Colleluori G, Chen R, Turin CG, et al. Aromatase inhibitors plus weight loss improves the hormonal profile of obese hypogonadal men without causing major side effects. Front Endocrinol (Lausanne). 2020;11:277. — DOI · via PubMed
• Taylor AP, Lee H, Webb ML, Joffe H, Finkelstein JS. Effects of testosterone and estradiol deficiency on vasomotor symptoms in hypogonadal men. J Clin Endocrinol Metab. 2016;101(9):3479-3486. — DOI · via PubMed
• Szulc P. Role of sex steroids hormones in the regulation of bone metabolism in men: evidence from clinical studies. Best Pract Res Clin Endocrinol Metab. 2022;36(2):101624. — DOI · via PubMed
• Helo S, Ellen J, Mechlin C, et al. A randomized prospective double-blind comparison trial of clomiphene citrate and anastrozole in raising testosterone in hypogonadal infertile men. J Sex Med. 2015;12(8):1761-1769. — DOI · via PubMed
• Yang C, Li P, Li Z. Clinical application of aromatase inhibitors to treat male infertility. Hum Reprod Update. 2021;28(1):30-50. — DOI · via PubMed
• Al Wattar BH, Rimmer MP, Teh JJ, et al. Pharmacological non-hormonal treatment options for male infertility: a systematic review and network meta-analysis. BMC Urol. 2024;24(1):158. — DOI · via PubMed
• Dias JP, Shardell MD, Carlson OD, et al. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters. Andrology. 2017;5(1):31-40. — DOI · via PubMed
• Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. — DOI · via PubMed
• U.S. Food and Drug Administration. ARIMIDEX (anastrozole) tablets — Highlights of Prescribing Information. — accessdata.fda.gov

Your trust is worth more than a sale.

More information →

This article is informational and is not medical advice. SCTS1 does not prescribe medications. All medical care, prescriptions and treatment plans are provided by licensed physicians through our partner platform, and preparations are dispensed by licensed pharmacies. Eligibility is determined by a licensed provider through medical evaluation. Anastrozole is not FDA-approved for the treatment of low testosterone in men; use for that purpose is off-label and is an individual medical decision. The doses mentioned correspond to those studied in the cited literature and do not replace your physician's instructions; do not start or change any medication on your own. Individual results vary and are not guaranteed.